Vanguard Personalized Indexing Management, LLC Rocket Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 17,382 shares of RCKT stock, worth $125,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,382Holding current value
$125,671% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
94.7MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$128 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$47.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$44.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$37.6 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$34.1 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $547M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...